Lv1
48 积分 2022-02-05 加入
Direct economic burden 1 year postoperation in Chinese adult patients with chronic rhinosinusitis with nasal polyps
13小时前
已完结
Use of omalizumab for management of idiopathic anaphylaxis
1天前
求助中
Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression
4天前
已完结
Cytokine-release hypersensitivity reaction after the first dose of benralizumab for severe eosinophilic asthma
4天前
求助中
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
6天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
12天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
13天前
已完结
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
21天前
已完结
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
21天前
已完结
From guidelines to algorithms: the future of AI-augmented asthma care
22天前
已关闭
皖公网安备34019202002308
